DUR 제도 및 DUR 고도화 시범사업에 대한 인식 탐구: 포커스 그룹 인터뷰 기법 중심의 질적 연구 Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews원문보기
Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews (FGI) between August 1, 2019 to December 31, 2019. The healthcare professionals and pa...
Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews (FGI) between August 1, 2019 to December 31, 2019. The healthcare professionals and patients who participated in the DUR modernization pilot project were included in the present study. Based on the type of project participation or medical institution, the participants were divided into the following four groups: group 1, hospital; group 2, clinic; group 3, pharmacy; and group 4, patient. Within each group, interviews were conducted under a pre-defined agenda to identify the implicit perceptions of the participants; the contents of the interviews were, then, categorized. Results: Healthcare professionals established a consensus on the positive aspects of the DUR system and DUR modernization pilot project. However, substantial concerns remain, such as additional workload associated with monitoring adverse events or acquiring consents from patients. Furthermore, a difference of opinion over the DUR convenience system was observed. Among 3 DUR convenience system, the personal medication history review service was highly utilized, but pop-up hold function and communication system was rarely used. Conclusion: We observed that systematic intervention using the DUR system is effective for both healthcare providers and consumers. Adverse events caused by inappropriate drug use can be prevented by continuous patient monitoring. Therefore, the role of DUR system needs to be expanded to establish a safe drug management system.
Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews (FGI) between August 1, 2019 to December 31, 2019. The healthcare professionals and patients who participated in the DUR modernization pilot project were included in the present study. Based on the type of project participation or medical institution, the participants were divided into the following four groups: group 1, hospital; group 2, clinic; group 3, pharmacy; and group 4, patient. Within each group, interviews were conducted under a pre-defined agenda to identify the implicit perceptions of the participants; the contents of the interviews were, then, categorized. Results: Healthcare professionals established a consensus on the positive aspects of the DUR system and DUR modernization pilot project. However, substantial concerns remain, such as additional workload associated with monitoring adverse events or acquiring consents from patients. Furthermore, a difference of opinion over the DUR convenience system was observed. Among 3 DUR convenience system, the personal medication history review service was highly utilized, but pop-up hold function and communication system was rarely used. Conclusion: We observed that systematic intervention using the DUR system is effective for both healthcare providers and consumers. Adverse events caused by inappropriate drug use can be prevented by continuous patient monitoring. Therefore, the role of DUR system needs to be expanded to establish a safe drug management system.
World Health Organization. WHO Pharmacovigilance Indicators: A Practical Manual For the Assessment of Pharmacovigilance Systems. Available from https://apps.who.int/iris/handle/10665/186642. Accessed Februrary 03, 2021.
World Health Organization. WHO Global Patient Safety Challenge: Medication Without Harm. Available from https://www.who.int/patientsafety/medication-safety/en/. Accessed Februrary 06, 2021
Jung DG. Achievements and chanllenges of Drug Utilization Review system. HIRA Research 2019;13(2):12-21
Kim DS, Jeon HL, Park JH. Drug Utilization Review system Implementation Plan for Medication Use in Geriatrics. Health Insurance Review & Assessment Service (HIRA); 2014. 105p.
Park BJ, Shin JY, Shin SM, et al. Long-term research plan for strategic development of DUR Information. Korea Institute of Drug Safety and Risk Management (KIDS); 2014. 145p
Koo BK, Shin JY, Kim MJ, et al. Retrospective drug utilization review on medicine abuse and DUR contraindicated medicines. Korea Institute of Drug Safety and Risk Management (KIDS); 2015. 353p
Kim DS, Byun JH, Cho DY, Shin HR, Kim BS, Kim MJ, et al. Establishing the basis for retrospective analysis of drug adverse effects and monitoring system. Health Insurance Review & Assessment Service (HIRA); 2018. 276p
Health Insurance Review & Assessment Service (HIRA). Establishment of patient safety platform through drug use monitoring system. Available from https://www.hira.or.kr/bbsDummy.do?pgmidHIRAA020041000100&brdScnBltNo4&brdBltNo9859. Assessed Februrary 07, 2021.
Song JE, Chae HJ, Park BL. Experiences of Sanhujori facility use among the first time mother by the focus group interview. Korean J Women Health Nurs 2015;21(3):184-96.
Kitzinger J. Qualitative Research: Introducing focus groups. BMJ 1995;311:299.
Lee SS, Kim AH. Teachers' perception of learning disabilities: A focus group study with general and special education teachers. Journal of Special Education 2008;20:113-37.
Bengtsson M. How to plan and perform a qualitative study using content analysis. NursingPlus Open 2016;2:8-14.
Organisation for Economic Co-operation and Development (OECD). Health Care Resources. 2020. Available from https://stats.oecd.org/Index.aspx?DataSetCodeHEALTH_REAC. Accessed Feb 01, 2021.
Lee CH, Lim HS, Kim YN, et al. Analysis of new patient's willingness to pay additional costs for securing satisfactory consultation time. Health policy and management 2017;27(1):39-46.
World Health Organization. WHO High 5s: Standaed Operating Procedures, 2014. Available from https://www.who.int/initiatives/high-5s-standard-operating-procedures. Accessed Feb 09, 2021.
Baseman JG, Revere D, Painter I, Toyoji M, Thiede H, Duchin J. Public health communications and alert fatigue. BMC Health Serv Res 2013;13:295.
Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000;50(6):829-40.
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.